NEW YORK, Aug 28- Microsoft Corp avoided a potentially costly setback to its financially troubled mobile phone business on Friday as the U.S. International Trade Commission declined to block the import of its devices in a longstanding patent dispute. The decision rejected a ruling in April by a U.S. trade judge who found that Microsoft had infringed two...» Read More
NEW YORK, March 10- A federal judge in California on Tuesday invalidated four Hewlett-Packard Co patents for being too abstract, marking a setback in the company's patent infringement lawsuit against competitor ServiceNow Inc. Hewlett-Packard last year accused its competitor, a Santa Clara, California- based software company, of infringing eight patents on...
NEW YORK, March 10- A California federal judge has invalidated four Hewlett-Packard Co patents for being too abstract, marking a setback in a major patent infringement lawsuit the company filed last year against competitor ServiceNow Inc..
NEW YORK, March 9- The U.S. Senate on Monday confirmed former Google Inc executive Michelle Lee to head the U.S. President Barack Obama's choice was approved by an unrecorded voice vote in the full Senate, just over a week after the Senate Judiciary Committee gave the nod to her nomination. The agency had gone without a confirmed leader since David Kappos, a former...
NEW YORK, March 9- The U.S. Senate on Monday confirmed former Google Inc executive Michelle Lee to head the U.S. President Barack Obama's choice was approved by an unrecorded voice vote in the full Senate, just over a week after the Senate Judiciary Committee gave the nod to her nomination. The Alexandria, Virginia- based federal agency which has more than 12,000...
SAN FRANCISCO, March 6- Microsoft Corp sued Kyocera Corp for patent infringement on Friday, alleging the Japanese company's Duraforce, Hydro and Brigadier cell phone lines violate seven Microsoft patents. Microsoft asked a Seattle federal judge to impose a U.S. sales injunction against Kyocera's infringing products, according to the lawsuit.
CNBC's Dominic Chu and International Business Times Tech Editor Michael Learmonth discuss the latest patent lawsuit against Apple.
Apple has been ordered to pay $532.9 million after a federal jury found iTunes software infringed patents owned by patent licensing firm Smartflash.
John Lechleiter, Eli Lilly CEO, runs through the quarterly numbers and provides insight to products coming off patents, R&D, and new Alzheimer's drugs in the pipeline.
Discussing innovation in the cloud computing space, with Jay Walker, Patent Properties chairman.
Jay Walker, Patent Properties chairman, discusses the U.S. patent data base and the idea behind the creation of his patent utility, with CNBC's Simon Hobbs.
GoPro dropped 12 percent in Tuesday's trading after news Apple was granted a camera patent. Jon Steinberg, Daily Mail North America CEO, and Mike Santoli, Yahoo! Finance senior columnist, provide perspective.
GoPro shares are taking a hit on news Apple has been granted a patent for a remote control camera system. Charlie Anderson, Dougherty and Co. senior research analyst, discusses whether this patent presents real competition to GoPro.
CNBC's Meg Tirrell speaks to John Lechleiter, Eli Lilly CEO, about the strength and outlook for the health care sector, and what new drugs he's most excited about.
Patent risk management company RPX announced a deal to buy out the bulk of the assets owned by patent consortium Rockstar.
A jury has told Apple to pay a Texas company $23.6 million for using SkyTel pager technology in its devices without permission, Bloomberg reported.
The "Squawk on the Street" crew discusses pressures facing Merck in regards to drugs coming off patent, and the play on pharma companies.
CNBC's Jim Cramer discusses news Regeneron's drug Eylea for treating diabetic macular edema created significantly greater improvement in visual acuity compared with Lucentis.
Apple's Beats and Bose have settled their patent infringement dispute, reports CNBC's Julia Boorstin.
U.S. regulators granted accelerated approval to Merck's Keytruda drug, a new type of melanoma treatment for patients with advanced melanoma.
Karan Girotra, professor at INSEAD, discusses Tesla's business model and their ability to grab the fascination of consumers.